THE term "muscle relaxants" has now come into common usage and embraces not only those drugs that act like d-tubocurarine (i.e. competitive inhibition or non-depolarization) but those which act in a similar manner to acetylcholine and bring about depolarization of the muscle-fibre: this group is represented by decamethonium (C.10) and succinyldicholine.
The basic concept is that on the arrival of an impulse at the end of a motor nerve, acetylcholine is responsible for bridging the gap between nerve and muscle fibre. These molecules excite the end-plate receptor on the fibre and trigger off a wave of depolarization which spreads along the fibre and brings about a mechanical contraction.
Methods of Study of Neuromuscular Transmission in Man
There are two main methods of studying neuromuscular block in man: (a) Volitional activity.-The muscle-strength of a conscious subject after varying doses of relaxants is recorded. The commonest method used is the measurement of hand grip-strength by squeezing a bulb attached to a column of mercury. Each determination requires the maximum possible effort on the part of the subject, which is sometimes difficult to obtain.
(b) Electromyographic studies.-The main nerve to a muscle, or group of muscles, is stimulated a variable number of times per second, and the resultant contraction of the muscle fibres is recorded either electrically or mechanically. The height of the action potential from peak to peak is taken as an index of the number of muscle fibres contracting.
The synchronous contraction of 150-300 muscle fibres representing a motor unit gives rise to an action-potential similar to that recorded on the electrocardiograph. This method can be used on either conscious or anesthetized patients, but the results obtained are not strictly comparable with those of volitional activity. Neuromuscular Block (1) Deficiency block.-AAny factor that interferes with the liberation of acetylcholine is capable of producing a block of this type; for example, procaine (Harvey, 1939) , botulinus toxin, and calcium deficiency act in this way. There is a failure of neuromuscular transmission but both the nerve and the muscle will respond to direct stimulation.
(2) Depolarization block.-The process is similar to that produced by acetylcholine in normal neuromuscular transmission but there is an increased duration and extent of depolarization. Succinyldicholine lasts only a few minutes because it is rapidly hydrolysed by the plasma into succinylmonocholine, which in turn is broken down to succinic acid and choline. In contrast, the action of decamethonium is prolonged because it is not hydrolysed in vivo but is excreted unchanged in the urine. A depolarization block due to either C.10 or succinyldicholine is preceded by muscle twitches, which represent the contraction of the muscle fibres before the onset of persistent depolarization and neuromuscular block. There are certain features of these fasciculations which are worth recalling:
Firstly, decamethonium produces a characteristic tightness of the jaw and calf muscles which occurs soon after the injection and may persist for many hours. Secondly, succinyldicholine leads to widespread fasciculations which are particularly prominent if the injection is given rapidly. Recovery is complete, but if the subject is ambulant after recovery a high proportion of cases (66 %) will develop generalized muscle stiffness after moving about on rising the following morning. This stiffness is similar to that experienced by an untrained subject the morning after some violent exercise (Churchill-Davidson, 1954) . Finally, electromyographically using a recording needle deeply placed in a muscle-it can be shown that these twitches are not, as might be expected, single muscle-fibre potentials, 'Thelfull paper will appear in Anesthesiology.
AUGUST but are full-action potentials, representing a whole motor unit of 150-300 muscle fibres contracting simultaneously. This might be taken as suggestive evidence of a central action of the drug, but the more likely explanation is that both succinyldicholine and C.10 stimulate a single motor end-plate which, in turn, by an anti-dromic reflex, fires off all the other fibres in the motor unit-the Masland-Wigton phenomenon (1940 in certain circumstances-after the intravenous injection of decamethonium or succinyldicholine in normal subjects. The mechanism is complex and requires knowledge of the response of cases of myasthenia gravis to both d-Tubocurarine and decamethonium.
(a) d-Tubocurarine and myasthenia: Bennett and Cash (1943) were the first to suggest the injection of d-tubocurarine as a diagnostic test for the presence of myasthenia, based on the finding that some of these cases showed a hypersensitivity to the drug. A reevaluation of this test has shown that only those muscles which are clinically weak have this hypersensitivity, whilst the other muscles will give a similar response to that of normal subjects. Consequently, respiratory paralysis is unlikely to follow a small test dose of dtubocurarine unless the myasthenic patient has signs of weakness in the bulbar muscles.
(b) Decamethonium and myasthenia. To understand the response to decamethonium in patients with myasthenia gravis there are two findings in normal subjects which must be emphasized. First, the average normal subject shows a profound degree of muscular weakness after the intermittent injection of a total dose of 2 5-3*0 mg. C.l0 over six minutes. Secondly, once this paresis is present an injection of an anticholinesterase-such as neostigmine or Tensilon-leads to a severe increase in the weakness.
In myasthenia the response to C.10 varies with the degree of myasthenic weakness already present. For example, a young girl (aged 21) who only had minimal myasthenic symptoms limited to her eyelids, showed no signs of paralysis even after the injection of 10 mg. C.10. Further studies suggest that if an even greater dose had been given the eyelid muscles would have been the first eventually to show signs of paresis. The fact that every motor end-plate showed resistance to the depolarizing activity of C.10 is evidence of the generalized character of this disease despite the fact that clinically it is only detectable in a limited group of muscles-in this patient, the eyelids.
At the other extreme, a severe case of myasthenia with generalized signs of weakness may show paralysis after the injection of as little as 1 0-2-5 mg. C.10. The failure of neuromuscular transmission, however, is not due to a block of the depolarization type but to one of non-depolarization (like d-tubocurarine); it is therefore readily reversible by neostigmine or Tensilon. There is also evidence that a brief period of depolarization precedes the change-over to this non-depolarization block (Churchill-Davidson and Richardson, 1953) .
These two types of response to decamethonium-identical with that observed in myasthenia -have been described as occurring physiologically in various species of animals (Zaimis, 1952). Thus, whereas the muscles of the cat, bird, and frog respond to C.10 by pure depolarization, those of the monkey, dog, and hare can exhibit features not only of depolarization but also of non-depolarization block with this substance. In the light of this work it appears that the muscles of normal subjects respond to C.10 in a similar manner to those of the cat, whereas the myasthenic muscle-response resembles that of the dog. an overdose of the muscle-relaxant. The correct dosage will necessarily vary with the amount of muscle-tissue and the state of the circulation of the patient. A poor peripheral blood flow-such as often occurs at the end of a long operation-will be attended by a prolonged action of the drug. Similarly, delayed renal excretion, as in hypotension and hypothermia, theoretically could lead to a longer action, but this is not very evident in clinical practice. The fact that the diaphragm-the principal muscle of respiration-is always (except in myasthenia) the last muscle to become paralysed may well be due to the excellent circulation resulting from its constant. exercise. The administration of two drugs, both of which have a similar action on the neuromuscular junction, may lead to summation and a persistent apncea. For example, a combination of ether and d-tubocurarine or decamethonium and neostigmine has been known to bring about this result.
Succinyldicholine, particularly when given as a continuous intravenous infusion, is apt to lead to a persistent apncea or weak respiratory activity in the occasional case. As far as is known it is hydrolysed in two stages. First, one molecule of choline is quickly split off, leaving succinylmonocholine. In the second stage, which takes place more slowly, succinylmonocholine is hydrolysed to succinic acid and choline. The process of hydrolysis is controlled by the enzyme pseudocholinesterase. Thus, on the one hand, a low plasma cholinesterase level may lead to a slower breakdown to the monocholine derivative (Bourne et al., 1952; Evans et al., 1952) . A low pseudocholinesterase activity is known to be associated with a number of factors, such as liver damage, undernutrition, cachexia and anticholinesterase drugs, but this may also occur in an otherwise apparently normal person (Calvert et al., 1954) .
On the other hand, succinylmonocholine, like its dicholine precursor, is capable of producing neuromuscular block if a sufficient concentration is reached: for animals this varies from 2 5-50 mg./kg. (Foldes et al., 1954) . On a molar basis the activity of the monocholine varies from 1/24-1/62 of the dicholine (Ellis et al., 1953) . Since the ratio of the molecular weights of the monocholine to the dicholine is 0-8, hydrolysis of 100 mg. of dicholine will lead to 80 mg. of the monocholine. Although it is unlikely that such a small amount of monocholine could have any effect, when doses of 1 5-2-0 grams are used then the accumulation of monocholine may be responsible for the prolongation of the paralysis. Finally, the prolonged apncea may be due to the presence of a dual block caused by either decamethonium or succinyldicholine. Although this type of response is rare, it must be seriously considered in view ofthe increasing number of reports in the literature of a prolonged paralysis-due to a depolarizing drug-which has been completely and rapidly reversed by the injection of an anticholinesterase drug (Hodges, 1953; Grant, 1952; Ruddell, 1952) . The presence of a dual block due to a depolarizing drug is known to occur in cases of myasthenia gravis; it is therefore possible that the end-plate response of normal subjects may change under persistent bombardment from one of pure depolarization to one of dual response.
Diagnosis of the Abnormal Response
If we are to make any progress in the diagnosis of the rare case of prolonged apnnca following the use of one of the muscle relaxants it is important that some attempt be made to isolate the causative factor during the period of paralysis. Electrical stimulation of a main nerve trunk will reveal whether the peripheral musculature is capable of a contraction: this will help to distinguish cases of central or respiratory centre depression from those due to causes affecting the neuromuscular junction. Blood samples can be used to estimate the carbon dioxide tension and the plasma-cholinesterase level. Finally, an intravenous injection of 10 mg. of Tensilon will help to elicit the possible presence of a dual block.
Tensilon is used-in preference to neostigmine-because it acts for only a few minutes, and were the block one of pure depolarization then it would be potentiated briefly, whereas a dual block would be completely reversed. Summary There are, therefore, three types of neuromuscular block that may be encountered in man: (1) Depolarization; (2) Non-depolarization; and (3) Dual block. This last type of block occurs in cases of myasthenia gravis, and possibly-in certain circumstances-in normal subjects after a depolarizing drug has been given. The possible causes of prolonged apncea following one of the muscle relaxants are reviewed and some suggestions to aid in the diagnosis of this condition are made.
Dr. H. 0. J. Collier: Dr. Churchill-Davidson has pointed out that movementafterrecoveryfrom succinylcholine is likely to bring on muscle-pains. Such movement would, of course, inevitably depend on release of acetylcholine at the motor end-plates of the muscles concerned. We know from the work of Professor C. A. Keele and his colleagues that dilute solutions of acetylcholine readily cause pain at the exposed site of a blister. I wonder therefore whether the acetylcholine itself released during movement is one factor in causing muscle-pain after succinylcholine. Some light might be thrown on this question by studies of the results of succinylcholine in E.C.T., in which movement might be suppressed (except in muscles stimulated directly by the electrodes) but acetylcholine would presumably be liberated at the motor end-plates in abundance.
Dr. Geoffrey Organe drew attention to the existence of a fairly wide variation in response of normal subjects to decamethonium. He quoted the case of a patient who opened his eyes a few minutes after the administration of 0 5 gram of thiopentone and 5 mg. of decamethonium, followed by nitrous oxide and oxygen.
Dr. T. Cecil Gray expressed great interest in the findings of Dr. Churchill-Davidson in regard to the reactions of muscles in myasthenic patients. If Dr. Churchill-Davidson's findings were correct it would seem that the "non-myasthenic" muscles in these patients proved an exception to the general rule that muscles which were sensitive to agents acting by non-depolarization block were resistant to those acting by depolarization and vice versa. These results showed that these "nonaffected" muscles were resistant to decamethonium-a depolarizing drug-but n1ot sensitive to d-tubocurarine, a non-depolarizing drug. Dr. Churchill-Davidson had not clearly indicated the experiments he had carried out to determine that these muscles were, in fact, not sensitive to d-tubocurarine. It would be hazardous, in his opinion, to jettison the test dose when using non-depolarizing relaxants because of Dr. Churchill-Davidson's findings. Even if it were a fact that the "nonmyasthenic" muscles in myasthenic patients did not show sensitivity to these drugs, nevertheless there was ample evidence, not only in the experience of many anesthetists but also in the literature, for the fact that test doses revealed patients who were hypersensitive-although not necessarily myasthenic.
Dr. Hermann Lehmann: As one who has worked on the relation between pseudocholinesterase level and response to succinyldi-and succinylmono-choline I should like to say that pseudocholinesterase of the plasma is only one of the factors involved in the regulation of this response and we cannot expect that all cases of apncea following the administration of these methonium compounds are due to low pseudocholinesterase. Even if a low pseudocholinesterase is responsible for such an apncea it may only start this condition and other factors will take over. Certainly simple pseudocholinesterase deficiency alone cannot cause more than a twenty minutes' apncea and a prolongation of the condition indicates that other influences are at play.
We have seen at St. Bartholomew's Hospital a number of incidences where people were resistant to succinyldicholine. We examined the succinyldicholine both by chromatography and by injection into rabbits and found that it was active and Dr. N. G. P. Butler, the anesthetist then working at St. Bartholomew's Hospital, was struck by the fact that the individuals were all being operated on for toxic goitre. Their pseudocholinesterase levels were at the higher limit of normal, about 120 to 130 units. This may, of course, be an indication of yet higher levels in the tissues. We examined a number of individuals suffering from toxic goitre but could not always find a particularly high pseudocholinesterase level and we abandoned this line of investigation. However, Professor R. H. S. Thompson and his colleagues, investigating hyperthyroidism from a different point of view, have recently reported that there is an overall increase of pseudocholinesterase level in this condition.
Dr. R. P. Harbord approved the suggestion that in patients with a prolonged apncea the blood CO. tension should be determined. Since this entailed pH and manometric CO2 content measurements on arterial blood, anaerobically withdrawn, he asked Dr. Churchill-Davidson if he thought it would be a more practical procedure to measure the CO2 tension of the patient's "alveolar" gases. Dr. Victor Goldman referred to the possibility of an abnormal response due to the formation of succinylmonocholine when large quantities were employed of the short-acting succinyldicholine. He had never experienced it even though he had used on many occasions a gram or even more in the form of a drip. In fact the rapid return of the normal respiratory rhythm after a long abdominal operation was one of the most striking features of the drip technique. What Dr. Goldman felt was a greater danger was the synergistic action of the depolarizers with procaine (Foldes et a., 1953, Science, 117, 383) and he asked Dr. Churchill-Davidson if he had any knowledge of the action of the short-acting muscle relaxants in the presence of high blood levels of procaine penicillin. This was an important point as so many patients to-day were operated upon under cover of a procaine penicillin "umbrella".
Dr. Churchill-Davidson, in reply, said, that five myasthenic patients had failed to reveal marked sensitivity to d-tubocurarine in their unaffected muscles. On the basis of Dr. Gray's "rule of opposites" one might expect the young girl mentioned above to be extremely sensitive in these muscles. This was not the case.
